Browse all clinical trials

Sponsor Updatedsort icon
Phase I Phase 1 Trial of Oral Ixabepilone Bristol-Myers Squibb 2009-05-20
Phase III Phase 3 Trial of Single-Dose Intravesical EOquin® as a Surgical Adjuvant for Noninvasive Bladder Cancer Spectrum Pharmaceuticals, Inc 2009-05-20
Phase III Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma Bristol-Myers Squibb 2009-05-20
Phase II Randomized Phase II of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-Resectable and/or Metastatic Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase IV Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis University of Oslo School of Pharmacy 2009-05-20
Phase III Alitretinoin in the Treatment of Chronic Hand Eczema Basilea Pharmaceutica 2009-05-20
Phase I A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer Bristol-Myers Squibb 2009-05-20
Phase III Phase IIIB Switching From Intravenous to Subcutaneous Study Bristol-Myers Squibb 2009-05-20
Phase IV A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome Bristol-Myers Squibb 2009-05-20
Phase I A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors Bristol-Myers Squibb 2009-05-20
Phase I A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer Bristol-Myers Squibb 2009-05-20
Phase III Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer National Cancer Institute (NCI) 2009-05-20
Effects of Smoking on Opioid Receptor Binding Using [(11)C]Carfentanil: an Imaging PET Study National Institute on Drug Abuse (NIDA) 2009-05-20
Phase III Methotrexate-Inadequate Response Study Bristol-Myers Squibb 2009-05-20
Phase I A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) Bristol-Myers Squibb 2009-05-20
Phase III Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia National Cancer Institute (NCI) 2009-05-20
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada Bristol-Myers Squibb 2009-05-20
Phase II Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery National Cancer Institute (NCI) 2009-05-20
Phase IV A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode Bristol-Myers Squibb 2009-05-20
Phase I Oral Topotecan to Treat Recurrent or Persistent Solid Tumors GlaxoSmithKline 2009-05-20
Phase II A Phase II Study of Belatacept (BMS-224818) With a Steroid-Free Regimen in Subjects Undergoing Kidney Transplantation Bristol-Myers Squibb 2009-05-20
Phase III 18-Week Add-on to Metformin Comparison of Saxagliptin and Sitagliptin Bristol-Myers Squibb 2009-05-20
Phase III Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder Astellas Pharma Inc 2009-05-20
Phase III Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia National Cancer Institute (NCI) 2009-05-20
Phase III Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures Pfizer 2009-05-20